Author

J. F. Kuehne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:proteomics· 1

Frequent Co-Authors

C. S. Falk· 2 shared J. Keil· 2 shared K. Beushausen· 2 shared A. Haverich· 1 shared A.-M. Hitz· 1 shared B. Wiegmann· 1 shared D. Jonigk· 1 shared E. Chichelnitskiy· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. S. Falk

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Donor tissue-resident memory-like T and NK cells generate a transient peripheral chimerism in lung transplant recipients, potentially protective from chronic lung allograft dysfunction

R. Bellmas-Sanz, A.-M. Hitz, B. Wiegmann, J. F. Kuehne, E. Chichelnitskiy, T. S. Kapellos, K.-A. Blaesing, J. Keil, K. Beushausen, W. Sommer, K. Haendler, M. Becker, K. Bassler, L.-M. Horn, D. Jonigk, , C. S. Falk

Donor TRM-like T and NK cells create a temporary chimerism in lung transplant recipients, possibly reducing the risk of chronic lung allograft dysfunction.

bioRxiv · Jun 16, 2023 · PreprintImmunology

Triple COVID-19 vaccination induces humoral and cellular immunity to SARS-CoV-2 with cross-recognition of the Omicron variant and IgA secretion

L. Ruhl, J. F. Kuehne, K. Beushausen, J. Keil, S. Christoph, J. Sauer, C. S. Falk

This study shows that triple COVID-19 vaccination increases IgG levels, boosts antibody inhibitory capacity against variants, and induces T cell responses, with Omicron breakthrough infections adding new variant-specific antibodies.

bioRxiv · Sep 22, 2022 · PreprintImmunology